Finding effective points by surrogate models with overcomplete bases

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effective actions with fixed points.

The specific form of the constant term in the asymptotic expansion of the heat-kernel on an axially-symmetric space with a codimension two fixed-point set of conical singularities is used to determine the conformal change of the effective action in four dimensions. Another

متن کامل

Two Methods for Estimating Overcomplete Independent Component Bases

Estimating overcomplete ICA bases is a difficult problem that emerges when using ICA on many kinds of natural data, e.g. image data. Most algorithms are based on approximations of the likelihood, which leads to computationally heavy procedures. Here we introduce two algorithms that are based on heuristic approximations and estimate an approximate overcomplete basis quite fast. The algorithms ar...

متن کامل

Two Approaches to Estimation of Overcomplete Independent Component Bases

Estimating overcomplete ICA bases is a difficult problem that emerges when using ICA on many kinds of natural data. Here we introduce two algorithms that estimate an approximate overcomplete basis quite fast in a high-dimensional space. The first algorithm is based on an assumption that the basis vectors are randomly distributed in the space, and the second on the gaussianization procedure.

متن کامل

Energy-Based Models for Sparse Overcomplete Representations

We present a new way of extending independent components analysis (ICA) to overcomplete representations. In contrast to the causal generative extensions of ICA which maintain marginal independence of sources, we define features as deterministic (linear) functions of the inputs. This assumption results in marginal dependencies among the features, but conditional independence of the features give...

متن کامل

Surrogate end points: hopes and perils.

In recent years, the cost of drug development has increased the demands on efficiency in the selection of suitable drug candidates; surrogate end points have emerged to improve this process, hoping that they can help reduce duration and cost of clinical trials. Additionally, they can help in solving ethical issues when measuring the clinical end point involves the application of risky or uncomf...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Computational and Applied Mathematics

سال: 2008

ISSN: 0377-0427

DOI: 10.1016/j.cam.2006.12.033